Activity Objectives:

Medicinal Cannabis: GI and Hepatic Disorders is organized by Thomas Jefferson University (TJU) and will be held from May 31, 2018 - May 31, 2020. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.

Course Objectives:
• Outline the endocannabinoid system's role in GI and Hepatic Disorders.
• Summarize current evidence both for and against cannabis use in GI and Hepatic Disorders.
• Explain the efficacy / lack of efficacy of currently approved therapeutic options for specific GI and Hepatic Disorders.
• Describe the risks and benefits of medicinal cannabinoids in GI and Hepatic Disorders.
• Discuss cannabinoid interactions with other medications.
• Discuss best practices for selection of cannabis forms, strains, ratios and dosages in specific GI and Hepatic Disorders.

Additional details will be posted as soon as they are available.

Intended Audience


Activity Payment Details

Activity Fee : USD $45.00

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


Thomas Jefferson University (TJU)

View Organizer Details


(215) 503-1111